These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 18806627

  • 1. Role of angiotensin II, endothelin-1 and L-type calcium channel in the development of glomerular, tubulointerstitial and perivascular fibrosis.
    Seccia TM, Maniero C, Belloni AS, Guidolin D, Pothen P, Pessina AC, Rossi GP.
    J Hypertens; 2008 Oct; 26(10):2022-9. PubMed ID: 18806627
    [Abstract] [Full Text] [Related]

  • 2. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
    Seccia TM, Belloni AS, Guidolin D, Sticchi D, Nussdorfer GG, Pessina AC, Rossi GP.
    J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
    [Abstract] [Full Text] [Related]

  • 3. Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.
    Seccia TM, Belloni AS, Kreutz R, Paul M, Nussdorfer GG, Pessina AC, Rossi GP.
    J Am Coll Cardiol; 2003 Feb 19; 41(4):666-73. PubMed ID: 12598081
    [Abstract] [Full Text] [Related]

  • 4. Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension.
    Rossi GP, Cavallin M, Belloni AS, Mazzocchi G, Nussdorfer GG, Pessina AC, Sartore S.
    Cardiovasc Res; 2002 Jul 19; 55(1):178-89. PubMed ID: 12062721
    [Abstract] [Full Text] [Related]

  • 5. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D, Tanabe A, Naruse M, Morikawa S, Ezaki T, Takano K.
    Hypertens Res; 2009 Sep 19; 32(9):807-15. PubMed ID: 19662019
    [Abstract] [Full Text] [Related]

  • 6. Role of endothelin in chronic renal failure--developments in renal involvement.
    Richter CM.
    Rheumatology (Oxford); 2006 Oct 19; 45 Suppl 3():iii36-8. PubMed ID: 16987832
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of T/L-type calcium channel blockers on tubulointerstitial fibrosis in obstructed kidneys in rats.
    Matsuda H, Mori T, Kurumazuka D, Kitada K, Hayashi T, Nagatoya K, Inoue T, Ukimura A, Matsumura Y, Ishizaka N, Kitaura Y.
    Urology; 2011 Jan 19; 77(1):249.e9-15. PubMed ID: 21071071
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.
    Hartner A, Porst M, Klanke B, Cordasic N, Veelken R, Hilgers KF.
    Nephrol Dial Transplant; 2006 Jul 19; 21(7):1778-85. PubMed ID: 16522658
    [Abstract] [Full Text] [Related]

  • 9. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats.
    Vernerová Z, Kramer HJ, Bäcker A, Cervenka L, Opocenský M, Husková Z, Vanourková Z, Eis V, Chábová VC, Tesar V, Malý J, Vanecková I.
    Vascul Pharmacol; 2008 Jul 19; 48(4-6):165-73. PubMed ID: 18372220
    [Abstract] [Full Text] [Related]

  • 10. Association between endothelin-1 and collagen deposition in db/db diabetic mouse kidneys.
    Mishra R, Emancipator SN, Kern TS, Simonson MS.
    Biochem Biophys Res Commun; 2006 Jan 06; 339(1):65-70. PubMed ID: 16297859
    [Abstract] [Full Text] [Related]

  • 11. Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.
    Seccia TM, Caroccia B, Gioco F, Piazza M, Buccella V, Guidolin D, Guerzoni E, Montini B, Petrelli L, Pagnin E, Ravarotto V, Belloni AS, Calò LA, Rossi GP.
    J Am Heart Assoc; 2016 Jul 21; 5(7):. PubMed ID: 27444511
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor induces an endothelin-mediated decline in glomerular filtration rate.
    Biswas P, Roy A, Gong R, Yango A, Tolbert E, Centracchio J, Dworkin LD.
    Am J Physiol Renal Physiol; 2005 Jan 21; 288(1):F8-15. PubMed ID: 15583218
    [Abstract] [Full Text] [Related]

  • 13. The selective TP receptor antagonist, S18886 (terutroban), attenuates renal damage in the double transgenic rat model of hypertension.
    Sebeková K, Ramuscak A, Boor P, Heidland A, Amann K.
    Am J Nephrol; 2008 Jan 21; 28(1):47-53. PubMed ID: 17890857
    [Abstract] [Full Text] [Related]

  • 14. Endothelin-1 in chronic renal failure and hypertension.
    Larivière R, Lebel M.
    Can J Physiol Pharmacol; 2003 Jun 21; 81(6):607-21. PubMed ID: 12839272
    [Abstract] [Full Text] [Related]

  • 15. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.
    Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, Ito T, Funahashi T.
    Arterioscler Thromb Vasc Biol; 2007 Sep 21; 27(9):1910-7. PubMed ID: 17626903
    [Abstract] [Full Text] [Related]

  • 16. Effects of maternal undernutrition on renal angiotensin II and chymase in hypertensive offspring.
    Chou HC, Wang LF, Lu KS, Chen CM.
    Acta Histochem; 2008 Sep 21; 110(6):497-504. PubMed ID: 18384844
    [Abstract] [Full Text] [Related]

  • 17. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W, Pittrow D.
    Eur J Clin Invest; 2006 Sep 21; 36 Suppl 3():78-88. PubMed ID: 16919017
    [Abstract] [Full Text] [Related]

  • 18. Ultrastructural islet study of early fibrosis in the Ren2 rat model of hypertension. Emerging role of the islet pancreatic pericyte-stellate cell.
    Hayden MR, Karuparthi PR, Habibi J, Wasekar C, Lastra G, Manrique C, Stas S, Sowers JR.
    JOP; 2007 Nov 09; 8(6):725-38. PubMed ID: 17993725
    [Abstract] [Full Text] [Related]

  • 19. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL, Qin XC, Pan ZY, Chen K, Zhang YF, Cui WY, Liu GS, Wang H.
    J Hypertens; 2008 Dec 09; 26(12):2326-38. PubMed ID: 19008712
    [Abstract] [Full Text] [Related]

  • 20. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats.
    Kon V, Hunley TE, Fogo A.
    Transplantation; 1995 Jul 15; 60(1):89-95. PubMed ID: 7624949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.